Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
Top Cited Papers
Open Access
- 19 May 2016
- journal article
- case report
- Published by American Society of Hematology in Blood
- Vol. 127 (20), 2406-2410
- https://doi.org/10.1182/blood-2015-08-665547
Abstract
Key Points. CD19-targeted CAR-T-cell therapy of patients with MLL-rearranged B-ALL effectively induced marrow remission of B-ALL.Patients with MLL-rearranged BKeywords
This publication has 14 references indexed in Scilit:
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialThe Lancet, 2014
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaScience Translational Medicine, 2014
- Lineage Switching in Acute Leukemias: A Consequence of Stem Cell Plasticity?Bone Marrow Research, 2012
- Lineage switch in childhood acute leukemia: An unusual event with poor outcomeAmerican Journal of Hematology, 2012
- A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cellsBlood, 2011
- Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trialThe Lancet Oncology, 2010
- Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 LeukemiaCancer Cell, 2008
- Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 studyLeukemia, 2006
- Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology GroupBlood, 2006
- Interleukin 6 induces myeloid differentiation of a human biphenotypic leukemic cell lineLeukemia Research, 1992